Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Free Cash Flow (2016 - 2025)

MedWellAI (MWAI) has disclosed Free Cash Flow for 11 consecutive years, with -$84968.0 as the latest value for Q4 2025.

  • On a quarterly basis, Free Cash Flow rose 60.79% to -$84968.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$642704.0, a 71.98% increase, with the full-year FY2025 number at -$850773.0, up 79.39% from a year prior.
  • Free Cash Flow was -$84968.0 for Q4 2025 at MedWellAI, up from -$170781.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $685233.0 in Q1 2022 to a low of -$1.4 million in Q4 2023.
  • A 5-year average of -$484209.7 and a median of -$289491.5 in 2022 define the central range for Free Cash Flow.
  • Biggest YoY gain for Free Cash Flow was 175.31% in 2022; the steepest drop was 261965.98% in 2022.
  • MedWellAI's Free Cash Flow stood at -$39606.0 in 2021, then tumbled by 659.56% to -$300831.0 in 2022, then crashed by 353.5% to -$1.4 million in 2023, then soared by 84.12% to -$216691.0 in 2024, then skyrocketed by 60.79% to -$84968.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Free Cash Flow are -$84968.0 (Q4 2025), -$170781.0 (Q3 2025), and -$108803.0 (Q2 2025).